Dr. Puspesh Upadhyay (CEO)
He has more than 12 years of experience in the CRO and CDMO industry, having worked with leading organizations including Sai Life Sciences, Jubilant Biosys, and Curia Global Hyderabad. His professional experience covers CRO R&D, Process R&D, CDMO and Peptide synthesis with extensive expertise for the development of a wide range of challenging chemical entities, including:
- Chiral molecules
- Azasugars
- Glycodendrimers
- Macrocyclic disulfide peptides using solid-phase synthesis
- Substituted pyrimidines
- Quinazoline derivatives
- Pyridine derivatives
- Pyridones
- Organophosphorus compounds
- PROTAC molecules
- Small molecules
- Complex and previously unreported heterocyclic compounds
- Advanced amino acid intermediates
In addition to hands-on synthetic chemistry, he was involved in scientific team management and end-to-end project execution, including:
- Managing and mentoring scientific teams
- Troubleshooting challenging synthetic routes
- Client communication and technical discussions
- Route design and synthetic strategy development
- Weekly project updates and follow-ups
- Participation in regular client teleconferences
- New target allocation and project planning
- Raw material procurement
- Interpretation of analytical data
- Coordination with QC team for the shipment of final compounds
- Laboratory safety and compliance.
This combination of technical expertise, project management, client interaction, and scientific leadership has provided comprehensive experience in managing projects from target identification and route design through synthesis, analytical characterization, and compound delivery.
Academic & Postdoctoral Experience
He has completed his postdoctoral research with Prof. Mats Larhed in the Department of Organic and Pharmaceutical Chemistry at Uppsala University, Sweden.
His research focused on:
Solid-Phase Synthesis of Macrocyclic Disulfide Dipeptides Using Fmoc Chemistry and Synthesis of Peptide Deformylase Inhibitors Using Unnatural Amino Acids.
In addition, he has awarded an ERASMUS MUNDUS Postdoctoral Fellowship by the University of Göttingen, Germany, which enabled him to carry out postdoctoral research at Uppsala University and Stockholm University, Sweden.
During this period, he has worked with Prof. Pher G. Andersson in the Department of Organic Chemistry on projects involving:
- Synthesis of N,P-ligated iridium catalysts and their application in the asymmetric hydrogenation of substituted olefins
- Synthesis of chiral bicyclic ligands and their application in the enantioselective synthesis of δ-lactones and β-nitro alcohols
Conferences & Scientific Presentations
During his postdoctoral and academic research career, he participated in several national and international scientific meetings, including:
- Komppa Symposium, Espoo, Finland, 2013
- 13th Spring Meeting of the Finnish Society for Synthetic Chemistry, Espoo, Finland, 2013
- 28th Organic Chemistry Winter Meeting, Skeikampen, Norway, 2013
- 4th INSA-KOSEF Symposium in Organic Chemistry, NCL, India, 2009
- NSC-10, Indian Institute of Science (IISc), Bangalore, India, February 2008, where he has presented a research poster.
Dr. D. S. Kothari Postdoctoral Fellowship
He was awarded the Dr. D. S. Kothari Postdoctoral Fellowship by the University Grants Commission (UGC), New Delhi, India.
Under this fellowship, he has worked for two years under the supervision of Prof. Dilip Dhavale, Department of Chemistry, University of Pune, on the project:
Synthesis of Glycodendrimer and their Application in Antileishmanial Activity.
The research involved the synthesis and application of glycodendrimers employing TRIS-glycine-β-alanine dipeptidic triazole chemistry.
PhD Research
He completed his Ph.D from National Chemical Laboratory (NCL), Pune, India, under the supervision of Dr. Pradeep Kumar, now Emeritus Scientist at NCL, Pune.
His doctoral research work focused on:
"Development of New Methodology Using Phosphorus Ylides and Enantioselective Synthesis of Hydroxylated Pyrrolidine and Piperidine Alkaloids."
During his academic career, he has published 10 research papers in an international journals and having a US patent.
Our Vision at HeteroSynth
With HeteroSynth Pvt Ltd, our objective is to build a reliable and long-term scientific partnership with pharmaceutical and biotechnology companies worldwide.
Our aim to provide:
- Custom synthesis and medicinal chemistry support
- Heterocyclic and complex molecule synthesis
- API intermediate synthesis
- Peptide synthesis
- Advanced intermediate synthesis
- Route design and synthetic methodology development
- Process R&D support
- Troubleshooting of challenging synthetic routes
- Cost-effective and timely delivery
- Flexible FFS and FTE collaboration models
With our combination of strong scientific expertise, extensive CRO/CDMO experience, project management capabilities, and a dedicated technical team, we look forward to supporting our clients in addressing challenging synthetic chemistry requirements.
We welcome opportunities to collaborate with pharmaceutical, biotechnology, CRO, and CDMO companies globally.
For collaboration and business inquiries:
Email:
info@heterosynth.com
Business Contact:
puspesh.u@heterosynth.com
